Extracorporeal life support in pediatric cardiac patients

Extracorporeal Life Support (ECLS) is a valuable tool in the management of neonates and older children with severe cardiac or respiratory failure. In this review, we focus on ECLS when used for neonatal and pediatric cardiac disease. Strict selection of patients and timely deployment are necessary t...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Matteo Di NARDO (Автор), Graeme MacLaren (Автор), Marco Marano (Автор), Corrado Cecchetti (Автор), Paola Bernaschi (Автор), Antonio Amodeo (Автор)
Формат:
Опубликовано: Frontiers Media S.A., 2016-10-01T00:00:00Z.
Предметы:
Online-ссылка:Connect to this object online.
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_03f98e2883a1449e89a1fe452c87e4e7
042 |a dc 
100 1 0 |a Matteo Di NARDO  |e author 
700 1 0 |a Graeme MacLaren  |e author 
700 1 0 |a Marco Marano  |e author 
700 1 0 |a Corrado Cecchetti  |e author 
700 1 0 |a Paola Bernaschi  |e author 
700 1 0 |a Antonio Amodeo  |e author 
245 0 0 |a Extracorporeal life support in pediatric cardiac patients 
260 |b Frontiers Media S.A.,   |c 2016-10-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2016.00109 
520 |a Extracorporeal Life Support (ECLS) is a valuable tool in the management of neonates and older children with severe cardiac or respiratory failure. In this review, we focus on ECLS when used for neonatal and pediatric cardiac disease. Strict selection of patients and timely deployment are necessary to optimize outcomes. Although every attempt should be made to deploy ECLS urgently rather than emergently, extracorporeal cardiopulmonary resuscitation (ECPR) is being increasingly used and reasonable survival rates have been achieved after initiation of ECLS during active compressions of the chest following in-hospital cardiac arrest. Contraindications to ECLS are falling over time, although lethal chromosomal abnormalities, severe irreversible brain injury, and extremely low gestational age and weight (<32 weeks gestation or <1.5 kg) remain firm contraindications. 
546 |a EN 
690 |a Extracorporeal Membrane Oxygenation 
690 |a Heart Failure 
690 |a Children 
690 |a neonates 
690 |a Ventricular assist device 
690 |a Extracorporeal life support 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 4 (2016) 
787 0 |n http://journal.frontiersin.org/Journal/10.3389/fped.2016.00109/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/03f98e2883a1449e89a1fe452c87e4e7  |z Connect to this object online.